« Previous
Next »
Gastroenterology
Volume 138, Issue 2
, Pages
522-530
, February 2010
Screening and Early Treatment of Migrants for Chronic Hepatitis B Virus Infection Is Cost-Effective
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: Prof. S.W. Schalm has received research grants and speaker's fees from GlaxoSmithKline and Bristol-Myers Squibb, respectively. The remaining authors disclose no conflicts.
Funding Supported by EU grant (LSHM-CT-2004-503359) VIRGIL to Erasmus MC and by an unrestricted grant from the Foundation for Liver Research to Erasmus MC.
PII: S0016-5085(09)01936-2
doi: 10.1053/j.gastro.2009.10.039
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 138, Issue 2
, Pages
522-530
, February 2010

